image

Main Profile

Pharmacovigilance Service Provider

Description in a few words:

Supplying drug benefit/risk evaluation service through data collection, literature screening and preparation of relevant reports to pharmaceutical companies. Holds partial or all pharmacovigilance responsibilities of the companies to the health authority.

Founder:

Dr. Seyfullah Dağıstanlı

Current Leadership:

Tayfun Erdönmez, General Manager

Founding Year:
2011

After working in the private sector, I realized that many local companies lack knowledge in terms of managing their responsibilities in this field. Small companies may not have the budget to invest in and implement a sound system. It was clear that local companies needed the assistance of experts. As a result, the market for contracted pharmacovigilance service companies emerged.

Services

174 companies outsourcing all of their pharmacovigilance responsibilities to DeltaPV

Number of pharmaceutical products responsible for:

4500+

R&D

R&D focus

VigidataPV software system that is used for collection and sorting out pharmacovigilance data.

Exports

Export % in revenues:

10%


List of export countries:

More than 55 countries in total, mainly: Ireland, Kazakhstan, Belarus, Egypt, UAE, Jordan, Lebanon, Croatia and other countries from MENA/CIS region

In More Depth



Official license of health authority for pharmacovigilance service provision:


Revenue or Growth Rate in past financial year:

15%


USP/ or a differentiating fact:

First company to provide pharmacovigilance services.

Pharmacovigilance service provider with the most in-depth data collection service thank to its software Vigidata.


Prominent partnerships/ clients

174+ pharmaceutical companies: Abbott, Abbvie, Baxter, Bayer, Gen İlaç, Shire, Novo Nordisk, P&G, Novartis, World Medicine and more.

Contact:



Website:

deltapv.com


E-mail:

ig@deltapv.com